The Center’s Pelvic Floor 6 hour course is a prerequisite for all of the courses in our curriculum. We base our courses on the movement of the pelvis and how it affects the rest of the female body. We will also look at the pelvic floor from a healthy stand- point rather than a problematic one. This course will offer an in depth look at the anatomy and function of the pelvic floor, its application to movement and the breath and will discuss the reasons for dysfunction and how many of these problems can be prevented. Our approach contains both the scientific evidenced based research and the more holistic viewpoint of this most intimate part of the female body.
It's still an open question, but there is no question that ALA represents a dietary difference between the sexes. For women, it's a healthful fat. For men with heart disease or major cardiac risk factors, it may also be a good choice — but men with more reason to worry about prostate cancer should probably get their omega-3s from fish and their vegetable fats largely from olive oil.
While women tend to need fewer calories than men, our requirements for certain vitamins and minerals are much higher. Hormonal changes associated with menstruation, child-bearing, and menopause mean that women have a higher risk of anemia, weakened bones, and osteoporosis, requiring a higher intake of nutrients such as iron, calcium, magnesium, vitamin D, and vitamin B9 (folate).
Changes in the way research ethics was visualised in the wake of the Nuremberg Trials (1946), led to an atmosphere of protectionism of groups deemed to be vulnerable that was often legislated or regulated. This resulted in the relative underrepresentation of women in clinical trials. The position of women in research was further compromised in 1977, when in response to the tragedies resulting from thalidomide and diethylstilbestrol (DES), the United States Food and Drug Administration (FDA) prohibited women of child-bearing years from participation in early stage clinical trials. In practice this ban was often applied very widely to exclude all women. Women, at least those in the child-bearing years, were also deemed unsuitable research subjects due to their fluctuating hormonal levels during the menstrual cycle. However, research has demonstrated significant biological differences between the sexes in rates of susceptibility, symptoms and response to treatment in many major areas of health, including heart disease and some cancers. These exclusions pose a threat to the application of evidence-based medicine to women, and compromise to care offered to both women and men.